Regresa al Registro Simple

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorMajem Tarruella, Margarita
dc.contributor.authorGarcía‑Martínez, E.
dc.contributor.authorMartinez, M.
dc.contributor.authorRodriguez‑Abreu, D.
dc.contributor.authorAlvarez, R.
dc.contributor.authorMuñoz Couselo, Eva
dc.date.accessioned2021-09-15T07:39:25Z
dc.date.available2021-09-15T07:39:25Z
dc.date.issued2020-02
dc.identifier.citationMajem M, García-Martínez E, Martinez M, Muñoz-Couselo E, Rodriguez-Abreu D, Alvarez R, et al. SEOM clinical guideline for the management of immune-related adverse events in patients treated with immune checkpoint inhibitors (2019). Clin Transl Oncol. 2020 Feb;22:213–222.
dc.identifier.issn1699-3055
dc.identifier.urihttps://hdl.handle.net/11351/6313
dc.descriptionInmunoterapia; Toxicidad; irAEs
dc.language.isoeng
dc.publisherSpringer
dc.relation.ispartofseriesClinical and Translational Oncology;22
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectImmunoteràpia - Efectes secundaris
dc.subjectCàncer - Tractament
dc.subjectProtocols clínics
dc.subject.meshImmunotherapy
dc.subject.mesh/adverse effects
dc.subject.meshNeoplasms
dc.subject.meshPractice Guidelines as Topic
dc.titleSEOM clinical guideline for the management of immune-related adverse events in patients treated with immune checkpoint inhibitors (2019)
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1007/s12094-019-02273-x
dc.subject.decsinmunoterapia
dc.subject.decs/efectos adversos
dc.subject.decsneoplasias
dc.subject.decsguías de práctica clínica como asunto
dc.relation.publishversionhttps://doi.org/10.1007/s12094-019-02273-x
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Majem M] Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau, c/Sant Antoni Maria Claret 167, 08025 Barcelona, Spain. Spanish Group for Cancer Immuno-Biotherapy, GÉTICA, Madrid, Spain. [García-Martínez E] Department of Medical Oncology and Hematology, Hospital Universitario Morales Meseguer, Murcia, Spain. Spanish Group for Cancer Immuno-Biotherapy, GÉTICA, Madrid, Spain. [Martinez M] Department of Medical Oncology, Hospital del Mar, Barcelona, Spain. [Muñoz-Couselo E] Servei de Medicina Oncològica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Melanoma and Other Skin Tumors Unit, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Rodriguez-Abreu D] Department of Medical Oncology, C.H.U. Insular-Materno Infantil de Gran Canaria, Las Palmas, Spain. Spanish Group for Cancer Immuno-Biotherapy, GÉTICA, Madrid, Spain. [Alvarez R] Department of Medical Oncology, Hospital Virgen de la Salud, Toledo, Spain
dc.identifier.pmid31993963
dc.identifier.wos000514525700006
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Regresa al Registro Simple